Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results

PO-332 Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results S.J. Harrison, L. Catley, T. Price, M.J. Millward, P. Padrik, C.R. Underhill, P.K. Cannell, F.J. Burrows, S.D. Reich, M. Trikha, A. Spencer The Peter MacCallum Cancer Centre; Mater Adult Hospital; Queen Elizabeth Hospital; Sir Charles; Tartu University Hospital; Border Medical Oncology and University of New South Wales; Royal Perth Hospital; Triphase Accelerator; Alfred Health-Monash University